The hidden cost of asthma

Analysis

The hidden cost of asthma

Asthma's $28 billion impact on Australia

Deloitte Access Economics estimates the total cost of asthma to Australia, including health, productivity and other financial costs, and the burden of disease.

This report has been commissioned by Asthma Australia, in partnership with the National Asthma Council Australia, as part of broader ongoing consultations to develop the National Asthma Strategy 2016-2020.

In this report, Deloitte Access Economics estimates the total cost of asthma to Australia, including health, productivity and other financial costs (economic costs) and 'burden of disease' costs (the loss of healthy life). To provide context to this analysis, the report provides an overview of the epidemiology of asthma, a discussion of prevalence and mortality and, finally, a list of recommendations for future asthma funding and research.

The hidden cost of asthma
  • Contact us
  • Submit RFP
  • Our Solutions

    Progress your business growth and development

    Take a look at the products and services we offer.

    Deloitte Access Economics

    Deloitte Access Economics offers a full suite of economic advisory services including economic forecasting, modelling, analysis and advisory services to help our clients plan for the future, understand the implications of major decisions, and navigate the complexities of economic policy.

    Health economics and social policy

    A dedicated practice of professionals with a passion for making an impact in the health and social services sector.

    Health service planning and commissioning

    Deloitte Access Economics offers health service planning and commissioning to help clients match health resources to healthcare needs and unlock improvements in healthcare outcomes for our clients' catchment populations.

Did you find this useful?